Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (101-110 of 400) with videos related to

Pageof 40
Sort By:
The Journal of Surgical Research|August 10, 2010
The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adenovirusesKrista Pennington, Quyen D Chu, David T Curiel, et al.
Virology|June 24, 2008
Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IXYizhe Tang, Long P Le, Qiana L Matthews, et al.
Journal of Molecular Biology|March 17, 2009
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabodyElena A Kashentseva, Joanne T Douglas, Kurt R Zinn, et al.
Journal of Virology|May 14, 2003
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytesFrancisco Noya, Cristina Balagué, N Sanjib Banerjee, et al.
Cancer Gene Therapy|February 12, 2005
Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectorsAnton V Borovjagin, Alexandre Krendelchtchikov, Nagarajan Ramesh, et al.
Virology|April 28, 2004
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptorsJoshua J Short, Alexander V Pereboev, Yosuke Kawakami, et al.
Veterinary Immunology and Immunopathology|April 22, 2008
An allogeneic hybrid-cell fusion vaccine against canine mammary cancerR Curtis Bird, Patricia Deinnocentes, Steven Lenz, et al.
Human Gene Therapy|September 7, 2002
Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapyAkseli Hemminki, Minghui Wang, Renee A Desmond, et al.
Plos One|December 31, 2013
Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in miceZhi Hong Lu, Sergey Kaliberov, Rebecca E Sohn, et al.
Molecular Imaging|August 7, 2004
Fluorescently labeled adenovirus with pIX-EGFP for vector detectionLong P Le, Maaike Everts, Igor P Dmitriev, et al.
Pageof 40

Showing results (101-110 of 400) with videos related to

Sort By:
Pageof 40
The Journal of Surgical Research|August 10, 2010
The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adenovirusesKrista Pennington, Quyen D Chu, David T Curiel, et al.
Virology|June 24, 2008
Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IXYizhe Tang, Long P Le, Qiana L Matthews, et al.
Journal of Molecular Biology|March 17, 2009
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabodyElena A Kashentseva, Joanne T Douglas, Kurt R Zinn, et al.
Journal of Virology|May 14, 2003
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytesFrancisco Noya, Cristina Balagué, N Sanjib Banerjee, et al.
Cancer Gene Therapy|February 12, 2005
Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectorsAnton V Borovjagin, Alexandre Krendelchtchikov, Nagarajan Ramesh, et al.
Virology|April 28, 2004
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptorsJoshua J Short, Alexander V Pereboev, Yosuke Kawakami, et al.
Veterinary Immunology and Immunopathology|April 22, 2008
An allogeneic hybrid-cell fusion vaccine against canine mammary cancerR Curtis Bird, Patricia Deinnocentes, Steven Lenz, et al.
Human Gene Therapy|September 7, 2002
Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapyAkseli Hemminki, Minghui Wang, Renee A Desmond, et al.
Plos One|December 31, 2013
Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in miceZhi Hong Lu, Sergey Kaliberov, Rebecca E Sohn, et al.
Molecular Imaging|August 7, 2004
Fluorescently labeled adenovirus with pIX-EGFP for vector detectionLong P Le, Maaike Everts, Igor P Dmitriev, et al.
Pageof 40